DCG-IV

DCG-IV is a research drug which acts as a group-selective agonist for the group II metabotropic glutamate receptors (mGluR_2/3).^[1] It has potent neuroprotective and anticonvulsant effects in animal studies,^[2][3][4][5] as well as showing anti-Parkinsonian effects,^[6][7] but also impairs the formation of memories.^[8][9]

DCG-IV

Identifiers
IUPAC name (1R,2R)-3-[(1S)-1-amino-2-hydroxy-2-oxoethyl]cyclopropane-1,2-dicarboxylic acid
CAS Number	147782-19-2 Y
PubChem CID	5310979
ChemSpider	4470521 N
CompTox Dashboard (EPA)	DTXSID00933208
ECHA InfoCard	100.161.971
Chemical and physical data
Formula	C7H9NO6
Molar mass	203.150 g·mol−1
3D model (JSmol)	Interactive image
SMILES [C@@H]1([C@@H](C1[C@@H](C(=O)O)N)C(=O)O)C(=O)O
InChI InChI=1S/C7H9NO6/c8-4(7(13)14)1-2(5(9)10)3(1)6(11)12/h1-4H,8H2,(H,9,10)(H,11,12)(H,13,14)/t2-,3-,4+/m1/s1 N Key:MATPZHBYOVDBLI-JJYYJPOSSA-N N
NY (what is this?)  (verify)